Celera, Abbott sign distribution agreement for KIF6 test
Celera and Abbott have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 in-vitro diagnostic test for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Sep 10
Celera and Abbott have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 in-vitro diagnostic test for…
19 Sep 10
Vascular Solutions and Shepherd Scientific have entered into a distribution agreement, under which Vascular Solutions distributes US Food…
19 Sep 10
Elixir Medical has initiated patient enrollment in Excella BD randomized clinical trial designed to evaluate the DESyne BD…
19 Sep 10
Emisphere Technologies' clinical study on its oral SNAC (Sodium N-[8-(2-hydroxybenzoyl) Amino] Caprylate) additive, based on Emisphere's Eligen Technology,…
19 Sep 10
Healthmed Services, a software development company, has introduced a new software technology Virtual Vantage to modernise remote patient…
19 Sep 10
OctoPlus, a drug delivery company, has entered into a feasibility agreement with a US based pharmaceutical firm regarding…
19 Sep 10
Nonin Medical, a provider of noninvasive physiological monitoring devices, has introduced its latest Continua Certified device 1000USB-C USB…
19 Sep 10
Accuray, a global provider in the field of radiosurgery, has presented the CyberKnife VSI System at ESTRO 29,…
19 Sep 10
InfraReDx, a medical device company developing intelligent cardiovascular diagnostic imaging technologies, is planning to present its new LipiScan…
19 Sep 10
Aeris Therapeutics, a developer and commercialiser of treatments for emphysema patients and other advanced lung diseases, has received…